Absolute Risk Reduction, Number Needed to Treat, Back-of-the-Envelope Cost Effectiveness Analysis, Testing Thresholds Revisited 26 October 2006 Michael.
Diabetes mellitus: An update D. Hunt March 2010. Significance of diabetes mellitus 5% of the population has diagnosed diabetes prevalence increases with.
VTE prevention: Real-world outcome data Domenico Pagano Consultant Cardiothoracic Surgeon Clinical Director Quality & Outcomes Research Unit University.
Reporting drugs and treatments Thomas Abraham JMSC 6090.
Electrophysiology 2011 Taresh Taneja, MD, FACC Assistant Professor of Medicine Texas A & M HSC COM Scott & White Hospital.
Results of the Longest and Largest Ever -Blockade Study in CHF Mortality Reduction beyond ß 1 -Blockade Pub.: Results: Poole-Wilson et al. Lancet 2003;362:7-13.
Maria Grazia Modena Milano, Milano, 9-10 Aprile 2010 9-10 Aprile 2010 Cattedra di Cardiologia, Dipartimento Emergenza-Urgenza, Direttore Prof.ssa MG. Modena.
Critical appraisal
Venous Leg Ulcers: Wound Preparation & Adjuvants to Healing
14.09 bp management in diabetes
Maurizio D’Amico MD — Clinical evidence – based safety and efficacy of a biolimus eluting stent with biodegradable polymer technology
Shock Gordon R. Bernard, M.D.
